Interim Data from the Medical Research Council QUARTZ Trial: Does Whole Brain Radiotherapy Affect the Survival and Quality of Life of Patients with Brain Metastases from Non-small Cell Lung Cancer?

Clinical Oncology

Volumn 25, Issue 3, 2013, Pages

  Langley, R E ^a   Stephens, R J ^a   Nankivell, M ^a   Pugh, C ^a   Moore, B ^b   Navani, N ^a,c   Wilson, P ^d   Faivre Finn, C ^e   Barton, R ^f   Parmar, M K B ^a   Mulvenna, P M ^g  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b Wales Cancer Research Network   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^e CHRISTIE HOSPITAL   (United Kingdom)

^f Queen's Centre for Oncology and Haematology   (United Kingdom)

^g Northern Centre for Cancer Care   (United Kingdom)

Author keywords

Brain metastases; Non small cell lung cancer; Quality of life; Quality adjusted life years; Steroids; Whole brain radiotherapy

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; DROWSINESS; FATIGUE; FEMALE; HUMAN; INSOMNIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT COMPLIANCE; PHENOTYPE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SURVIVAL RATE; WEAKNESS;

AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CRANIAL IRRADIATION; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84873080012     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.11.002     Document Type: Article

References (21)

1. Barnholtz-Sloan J.S., Sloan A.E., Davis F.G., Vigneau F.D., Lai P., Sawaya R.E. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004, 22(14):2865-2872.
2. Ricciardi S., de Marinis F. Multimodality management of non-small cell lung cancer patients with brain metastases. Curr Opin Oncol 2010, 22(2):86-93.
3. Ceresoli G.L., Reni M., Chiesa G., et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 2002, 95(3):605-612.
4. Law A., Karp D.D., Dipetrillo T., Daly B.T. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma. Cancer 2001, 92(1):160-164.
5. Sperduto P.W., Chao S.T., Sneed P.K., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77(3):655-661.
6. Priestman T.J., Dunn J., Brada M., Rampling R., Baker P.G. Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. Clin Oncol (R Coll Radiol) 1996, 8(5):308-315.
7. Chao J.H., Phillips R., Nickson J.J. Roentgen-ray therapy of cerebral metastases. Cancer 1954, 7(4):682-689.
8. Chu F.C., Hilaris B.B. Value of radiation therapy in the management of intracranial metastases. Cancer 1961, 14:577-581.
9. Barnes E.A., Chow E., Tsao M.N., et al. Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76(1):187-192.
10. Borgelt B., Gelber R., Kramer S., et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980, 6(1):1-9.
11. Borgelt B., Gelber R., Larson M., Hendrickson F., Griffin T., Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981, 7(12):1633-1638.
12. Sause W.T., Crowley J.J., Morantz R., et al. Solitary brain metastasis: results of an RTOG/SWOG protocol evaluation surgery + RT versus RT alone. Am J Clin Oncol 1990, 13(5):427-432.
13. Komarnicky L.T., Phillips T.L., Martz K., Asbell S., Isaacson S., Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991, 20(1):53-58.
14. Tsao M.N., Lloyd N., Wong R., Chow E., Rakovitch E., Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 2006, 3:CD003869.
15. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208.
16. Billingham L.J., Abrams K.R. Simultaneous analysis of quality of life and survival data. Stat Methods Med Res 2002, 11(1):25-48.
17. Gerrard G.E., Prestwich R.J., Edwards A., et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol (R Coll Radiol) 2003, 15(7):422-428.
18. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37(4):745-751.
19. Green S.J., Fleming T.R., O'Fallon J.R. Policies for study monitoring and interim reporting of results. J Clin Oncol 1987, 5(9):1477-1484.
20. Lilford R.J., Braunholtz D., Edwards S., Stevens A. Monitoring clinical trials - interim data should be publicly available. Br Med J 2001, 323(7310):441-442.
21. Thornton J.G., Hornbuckle J., Vail A., Spiegelhalter D.J., Levene M. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004, 364(9433):513-520.